Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Nov 12 - Nov 17
Offering a non-invasive, peptide nasal delivery to your clinical research
EBioMedicine 2 , 17351750 (2015)
GIP (Glucose-Dependent Insulinotropic Polypeptide) Another incretin hormone that enhances insulin release and influences fat metabolism
Phase 2a MASLD trial (48 weeks, liver disease population) In participants with metabolic dysfunction-associated steatotic liver disease (formerly NAFLD/NASH), retatrutide demonstrated remarkable liver fat reduction
Among the most promising combinations is the synergistic use of Tesamorelin and Ipamorelin two growth hormone-releasing peptides with distinct yet complementary mechanisms of action
US$ 24.04
US$ 29.56
US$ 21.26
US$ 22.64
US$ 20.98
US$ 25.19
US$ 29.51
